Vaccentis goes Vienna – New EU Hub opens in the Seestadt biotech cluster!
We are pleased to announce the opening of our new location in the Seestadt biotech cluster in Vienna. The site will serve as our central EU competence center, will bring together our research and development activities and associated regulatory processes. The expansion to Vienna – one of Europe’s largest biotech hubs – is a strategic step toward securing EMA approval for our innovative cancer vaccine VCC-001.
